Cargando…
Adoption of World Health Organization Best Practices in Clinical Trial Transparency Among European Medical Research Funder Policies
IMPORTANCE: Research funders can reduce research waste and publication bias by requiring their grantees to register and report clinical trials. OBJECTIVE: To determine the extent to which 21 major European research funders’ efforts to reduce research waste and publication bias in clinical trials mee...
Autores principales: | Bruckner, Till, Rodgers, Florence, Styrmisdóttir, Lea, Keestra, Sarai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344358/ https://www.ncbi.nlm.nih.gov/pubmed/35913742 http://dx.doi.org/10.1001/jamanetworkopen.2022.22378 |
Ejemplares similares
-
Improving clinical trial transparency at UK universities: Evaluating 3 years of policies and reporting performance on the European Clinical Trial Register
por: Mirjam Keestra, Sarai, et al.
Publicado: (2022) -
Are European clinical trial funders policies on clinical trial registration and reporting improving? A cross-sectional study
por: O’Riordan, Marguerite, et al.
Publicado: (2023) -
Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov—evaluation of a new tracking tool for the US clinical trial registry
por: Keestra, Sarai Mirjam, et al.
Publicado: (2021) -
Noncommercial US Funders’ Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability
por: Whitlock, Evelyn P., et al.
Publicado: (2019) -
Funders’ data-sharing policies in therapeutic research: A survey of commercial and non-commercial funders
por: Gaba, Jeanne Fabiola, et al.
Publicado: (2020)